Literature DB >> 17925550

Human papillomavirus-16 is the predominant type etiologically involved in penile squamous cell carcinoma.

Daniëlle A M Heideman1, Tim Waterboer, Michael Pawlita, Pien Delis-van Diemen, Ingo Nindl, Joost A Leijte, Johannes M G Bonfrer, Simon Horenblas, Chris J L M Meijer, Peter J F Snijders.   

Abstract

PURPOSE: Human papillomavirus (HPV) infections are suggested to be involved in the development of penile squamous cell carcinoma (SCC), but comprehensive studies to define the association are limited. Therefore, we performed molecular and serologic analyses for a broad spectrum of HPV types on a large series of 83 penile SCCs, and we compared serological findings to those of age-matched male controls (N = 83).
METHODS: Penile SCCs were subjected to detection and typing assays for mucosal and cutaneous HPVs and to subsequent, type-specific viral load and viral gene expression assays. Sera of patients and of controls were analyzed for type-specific mucosal and cutaneous HPV L1, E6, and/or E7 antibodies using bead-based, multiplex serology.
RESULTS: HPV DNA of mucosal and/or cutaneous types was found in 46 of 83 (55%) penile SCCs. HPV16 was the predominant type, appearing in 24 (52%) of 46 of penile SCCs. The majority of HPV16 DNA-positive SCCs (18 of 24; 75%) demonstrated E6 transcriptional activity and a high viral load. Additionally, HPV16 molecular findings were strongly associated with HPV16 L1-, E6-, and E7-antibody seropositivity. Furthermore, serologic case-control analyses demonstrated that, in addition to the association of HPV16 with penile SCC, seropositivity against any HPV type was significantly more common in patients compared with in controls. HPV18 and HPV6 seropositivity were associated with HPV16-negative SCCs but were not correlated to molecular findings.
CONCLUSION: HPV16 is the main HPV type etiologically involved in the development of penile SCC. Although individuals who develop penile SCC show a greater prior exposure to a broad spectrum of HPV types, insufficient evidence was found to claim a role for HPV types other than HPV16 in penile carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17925550     DOI: 10.1200/JCO.2007.12.3182

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  55 in total

1.  Organ-sparing treatment of penile cancer with interstitial pulsed-dose-rate brachytherapy.

Authors:  Johannes Seibold; Vratislav Strnad; Rainer Fietkau
Journal:  Strahlenther Onkol       Date:  2016-06-09       Impact factor: 3.621

2.  Genital Human Papillomavirus Infection Progression to External Genital Lesions: The HIM Study.

Authors:  Staci L Sudenga; Donna J Ingles; Christine M Pierce Campbell; Hui-Yi Lin; William J Fulp; Jane L Messina; Mark H Stoler; Martha Abrahamsen; Luisa L Villa; Eduardo Lazcano-Ponce; Anna R Giuliano
Journal:  Eur Urol       Date:  2015-06-06       Impact factor: 20.096

3.  Comparison of the Natural History of Genital HPV Infection among Men by Country: Brazil, Mexico, and the United States.

Authors:  Staci L Sudenga; B Nelson Torres; Roberto Silva; Luisa L Villa; Eduardo Lazcano-Ponce; Martha Abrahamsen; Maria Luiza Baggio; Jorge Salmeron; Manuel Quiterio; Anna R Giuliano
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-04-26       Impact factor: 4.254

Review 4.  Age-specific human papillomavirus antibody and deoxyribonucleic acid prevalence: a global review.

Authors:  Sarah M Tiggelaar; Margaret J Lin; Raphael P Viscidi; Jia Ji; Jennifer S Smith
Journal:  J Adolesc Health       Date:  2012-02       Impact factor: 5.012

5.  Buried penis: An unrecognized risk factor in the development of invasive penile cancer.

Authors:  Alym Abdulla; Dean Daya; Jehonathan Pinthus; Timothy Davies
Journal:  Can Urol Assoc J       Date:  2012-10       Impact factor: 1.862

6.  Cutaneous human papillomavirus types detected on the surface of male external genital lesions: a case series within the HPV Infection in Men Study.

Authors:  Christine M Pierce Campbell; Jane L Messina; Mark H Stoler; Drazen M Jukic; Massimo Tommasino; Tarik Gheit; Dana E Rollison; Laura Sichero; Bradley A Sirak; Donna J Ingles; Martha Abrahamsen; Beibei Lu; Luisa L Villa; Eduardo Lazcano-Ponce; Anna R Giuliano
Journal:  J Clin Virol       Date:  2013-10-16       Impact factor: 3.168

7.  Human papillomavirus is not associated with colorectal cancer in a large international study.

Authors:  Michele C Gornick; Xavier Castellsague; Gloria Sanchez; Thomas J Giordano; Michelle Vinco; Joel K Greenson; Gabriel Capella; Leon Raskin; Gad Rennert; Stephen B Gruber; Victor Moreno
Journal:  Cancer Causes Control       Date:  2010-01-20       Impact factor: 2.506

8.  Burden of invasive squamous cell carcinoma of the penis in the United States, 1998-2003.

Authors:  Brenda Y Hernandez; Jill Barnholtz-Sloan; Robert R German; Anna Giuliano; Marc T Goodman; Jessica B King; Serban Negoita; Jose M Villalon-Gomez
Journal:  Cancer       Date:  2008-11-15       Impact factor: 6.860

Review 9.  HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women.

Authors:  Maura L Gillison; Anil K Chaturvedi; Douglas R Lowy
Journal:  Cancer       Date:  2008-11-15       Impact factor: 6.860

Review 10.  [Value of targeted therapy for penile cancer].

Authors:  A Heidenreich; D Thüer; D Pfister
Journal:  Urologe A       Date:  2008-10       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.